Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A genetic variant of Mendelian susceptibility to mycobacterial disease characterized by a partial deficiency leading to impaired IFN-gamma immunity and, consequently, recurrent, moderately severe infections with bacillus Calmette-Guerin (BCG) and other environmental mycobacteria (EM).
Features include: Salmonella osteomyelitis, Recurrent mycobacterium avium complex infections, Recurrent mycobacterial infections, and Generalized lymphadenopathy and 2 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Blood and immune system | 3 | Recurrent mycobacterium avium complex infections, Recurrent mycobacterial infections, Immunodeficiency |
Bones and joints | 2 | Salmonella osteomyelitis, Bone infection (osteomyelitis) |
IFNGR1 encodes interferon gamma receptor 1 (489 aa). Receptor subunit for interferon gamma/INFG that plays crucial roles in antimicrobial, antiviral, and antitumor responses by activating effector immune cells and enhancing antigen presentation. Highest expression in Lung (268.2 TPM) and Spleen (207.8 TPM).
Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency is associated with mutations in the IFNGR1 gene on chromosome 6.
The IFNGR1 protein participates in Binding of STAT1 to p-IFNGR1 pathway.
IFNGR1 is classified as a druggable target (Clinically Actionable and Druggable Genome categories) with score 39.2.
Genetic testing for IFNGR1 is available. Testing is considered confirmatory for diagnosis.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 11:36 PM UTC
Online Mendelian Inheritance in Man
European rare disease database